Lupin has received final approval for its Clobetasol Propionate Cream USP, 0.05% from the USFDA to market a generic version of Fougera Pharmaceuticals Inc's Temovate Cream, 0.05%.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
